Our People

Ludwig Cancer Research is a community of the world's leading scientists, all pursuing innovative ways to prevent and control cancer. The Ludwig Institute for Cancer Research has an expansive research presence through its branches and collaborative laboratories around the world. In addition, the Ludwig Centers are scientific partners operating independently at six elite U.S. institutions. Learn more.

Board of Directors

A Board of Directors has the ultimate responsibility for the Ludwig Institute for Cancer Research and the Ludwig Fund. Although they are separate Boards, the members are the same. Several board members also served as trustees of the Virginia and D.K. Ludwig Fund for Cancer Research, which oversaw the endowment of the six Ludwig Centers in the United States.

John L. Notter, Chairman of the Board, Ludwig Institute for Cancer Research
John L.
Notter
Chair of the Board; Board member, Conrad N. Hilton Foundation
Olivier Dunant, Board of Directors, Ludwig Institute for Cancer Research
Olivier
Dunant
Senior Partner, Law firm of Borel & Barbey
John D. Gordan III, Board of Directors, Ludwig Institute for Cancer Research
John D.
Gordan III
Senior Counsel (retired), Law firm of Morgan, Lewis & Bockius
Samuel
Hellman, MD
A.N. Pritzker Distinguished Service Professor Emeritus, University of Chicago
Barbara S.
Jones
Partner, Bracewell LLP
Adolf E. Kammerer, Board of Directors, Ludwig Institute for Cancer Research
Adolf E.
Kammerer
Partner (retired), Law firm of Niederer Kraft & Frey
Philip A.
Pizzo, MD
Professor, Stanford University School of Medicine
Edward A. McDermott Jr., President and Chief Executive Officer, Ludwig Institute for Cancer Research
President and Chief Executive Officer
Scientific Director
Executive management

Executive officers of the Ludwig Institute for Cancer Research and the LICR Fund are appointed by the respective Board of Directors and, together with their department heads, oversee worldwide efforts.

Edward A. McDermott Jr., President and Chief Executive Officer, Ludwig Institute for Cancer Research
President and Chief Executive Officer
Scientific Director
Jonathan C.A. Skipper, Executive Vice President for Technology Development, Ludwig Institute for Cancer Research
Executive Vice President for Technology Development
Deputy Scientific Director
Richard D.J. Walker, Chief Financial Officer, Ludwig Institute for Cancer Research
Chief Financial Officer and Secretary to the Board
Vice President for Human Resources
Pär Olsson, Ludwig Institute for Cancer Research
Vice President for Intellectual Property
Vice President for Communications
Ralph Venhaus, Ludwig Institute for Cancer Research
Vice President for Clinical Trials Management
Xing Chen, The LICR Fund Inc.
Vice President/Chief Investment Officer, LICR Fund Inc.
Webster Cavenee, Director of Strategic Alliances in Central Nervous System Cancers, Ludwig Institute for Cancer Research
Director of Strategic Alliances in Central Nervous System Cancers
Scientific Advisory Committee

The Scientific Advisory Committee is a group of distinguished independent scientists and clinicians appointed by the Scientific Director of the Ludwig Institute to advise on emerging areas of cancer research and development that might help the Institute fulfill its mission. The group also assists in the scholarly review of Institute scientists.

Philip D. Greenberg, Scientific Advisory Committee, Ludwig Institute for Cancer Research
Fred Hutchinson Cancer Research Center
Stanford University
Karen Vousden, Scientific Advisory Committee, Ludwig Institute for Cancer Research
Cancer Research UK Beatson Institute
Johns Hopkins Kimmel Cancer Center
MD Anderson Cancer Center